These data demonstrated that HRSD-24 score, blood Aβ42/40 ratio, and Tau-pT181 level were strongly associated with sleep-disordered breathing in MCI patients due to Alzheimer’s disease. This evidence concerns the gene MAPT and sleep apnea syndrome.